The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver

• Published in: The Journal of biological chemistry Vol. 259; no. 15; pp. 9662 - 9666
• Main Authors: Arbeeny, C M, Rifici, V A
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Elsevier Inc 10.08.1984; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Apolipoproteins - metabolism; Apolipoproteins B; Apolipoproteins E; Biological and medical sciences; Cell physiology; Chylomicrons - metabolism; Electrophoresis, Polyacrylamide Gel; Ethinyl Estradiol - pharmacology; Fundamental and applied biological sciences. Psychology; Lipoproteins, VLDL - metabolism; Liver - metabolism; Male; Miscellaneous; Molecular and cellular biology; Perfusion; Rats; Rats, Inbred Strains; Receptors, Cell Surface - metabolism; Receptors, LDL; Vertebrata; Regulation(control); Mammalia; Chylomicron; Rat; Perfusion; Liver; Preβ-Lipoprotein; Rodentia; Lipoprotein; Biological activity
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(17)42752-9

The regulation of the hepatic uptake of chylomicron remnants and very-low-density lipoprotein (VLDL) remnants was studied in the rat using a nonrecirculating liver perfusion system. The hepatic removal of remnant lipoproteins was shown to be by receptor-mediated processes since the concentration-dependent uptake was saturable and reductive methylation of the particles reduced the uptake of each lipoprotein by two-thirds. Treatment of liver donor rats with 17 alpha-ethinyl estradiol resulted in a 2-fold increase in the hepatic uptake of VLDL remnants, while cholesterol feeding of liver donor rats caused complete suppression of the receptor-mediated uptake of VLDL remnants. Chylomicron remnant removal was unaffected by estradiol administration and only slightly diminished by cholesterol feeding. The results of competition studies also indicated that a specific chylomicron remnant receptor exists in the liver. Apoprotein E was shown to be required for the receptor-mediated uptake of both remnant lipoproteins. Chylomicron remnants which contained no apoprotein E and VLDL remnants which contained reductively methylated apoprotein E were removed by the liver to about one-third of the extent of native particles. Thus the hepatic uptake of remnant lipoproteins occurs by receptor-mediated processes and the specific removal of both particles is mediated by apoprotein E. In addition, the uptake of VLDL remnants is regulated by the same factors that control hepatic low-density lipoprotein removal, while chylomicron remnant removal is unaffected by these factors.